Arbyn

Attoh

Chernesky

Clad

Cuzick

Czegledy

Du Chateau

E. Munson

Erali

Giuliani

Harvey

Ikeda-Dantsuji

K. L. Munson

L. Kroeger

Lambert

M. Napierala

Monsonego

Munson

Ovestad

P. J. Dillon

R. Amrhein

R. Hudspeth

Ratnam

S. Balzer

Solomon

Stoler

Webber

Wong

Zhang

ABSTRACT
          
            Assessment of 4,056 cytology collections by Cervista HPV HR and APTIMA HPV yielded 88.7% concordance, with increased detection by Cervista in patients with atypical squamous cells of undetermined significance (ASC-US) and patients negative for intraepithelial lesions and malignancy (NILM) (
            P
            ≤ 0.02). Both assays detected ≥91.7% of cervical intraepithelial neoplasia grade 2+ (CIN2+) lesions. A total of 262 specimens demonstrated luminescence within all three Cervista oligonucleotide mixtures (triple positive). APTIMA HPV and PCR-based microarray confirmed triple-positive results at rates of 7.3% and 5.9%, respectively.
          </jats:p

Erik Munson

Lynn Kroeger

Sandra Balzer

Robert Amrhein

Kimber L. Munson

Maureen Napierala

Richard Hudspeth

Patrick J. Dillon

Crossref

Journal of Clinical Microbiology

Comparison of Commercial Hybridization and Automated Transcription-Mediated Amplification Modalities for Detection of High-Risk Human Papillomavirus Nucleic Acid

Comparison of Commercial Hybridization and Automated Transcription-Mediated Amplification Modalities for Detection of High-Risk Human Papillomavirus Nucleic Acid

Abstract

Similar works

Full text

Available Versions

Crossref